A detailed history of Cwm, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 481 shares of RAPT stock, worth $577. This represents 0.0% of its overall portfolio holdings.

Number of Shares
481
Previous 782 38.49%
Holding current value
$577
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$1.76 - $3.75 $529 - $1,128
-301 Reduced 38.49%
481 $1,000
Q2 2024

Jul 09, 2024

BUY
$2.89 - $9.38 $2,075 - $6,734
718 Added 1121.88%
782 $2,000
Q1 2024

Apr 05, 2024

BUY
$6.87 - $26.45 $288 - $1,110
42 Added 190.91%
64 $1,000
Q4 2023

Feb 01, 2024

BUY
$11.28 - $25.46 $248 - $560
22 New
22 $1,000
Q1 2023

Apr 28, 2023

BUY
$17.19 - $30.8 $378 - $677
22 New
22 $0

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $35.6M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.